Retinal Diseases
|
group |
Eye Diseases
|
Disease or Syndrome
|
714
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Cutaneous Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
507
|
248
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.010 |
None |
1.000 |
1 |
3
|
2013 |
2013 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Adenomatous Polyps
|
disease |
Neoplasms
|
Neoplastic Process
|
120
|
20
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Medullary carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
81
|
2
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neuromuscular inhibition
|
disease |
|
Disease or Syndrome
|
72
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Thyroid Gland Oncocytic Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Scoliosis, unspecified
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
850
|
135
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Taste Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
NEUROTICISM
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
141
|
54
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Columnar Cell Hyperplasia of the Breast
|
disease |
|
Neoplastic Process
|
38
|
2
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Tinea Capitis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Tobacco Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
34
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Gram-Negative Bacterial Infections
|
group |
Infections
|
Disease or Syndrome
|
24
|
3
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Poorly Differentiated Thyroid Carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
54
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hurthle Cell Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
170
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |